Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samba-01: Inhaled Insulin PK/PD in Type 1 Diabetes
NCT02713841Phase 2Completed
- Sponsor
- Aerami Therapeutics
- Start
- May 2013
- Primary completion
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of Dance-501 in type 1 diabetes mellitus (T1D), sponsored by Aerami Therapeutics. Started May 2013; status: completed.
02
Drugs
Dance-501
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02713841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713841.